These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15822051)

  • 41. Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus.
    Freedman BI; Bowden DW; Sale MM; Langefeld CD; Rich SS
    Hypertension; 2006 Jul; 48(1):8-13. PubMed ID: 16735643
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population.
    Maeda S; Osawa N; Hayashi T; Tsukada S; Kobayashi M; Kikkawa R
    Kidney Int Suppl; 2007 Aug; (106):S43-8. PubMed ID: 17653210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects.
    Fava S; Azzopardi J; Hattersley AT; Watkins PJ
    Am J Kidney Dis; 2000 Apr; 35(4):708-12. PubMed ID: 10739793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study.
    Hanson RL; Craig DW; Millis MP; Yeatts KA; Kobes S; Pearson JV; Lee AM; Knowler WC; Nelson RG; Wolford JK
    Diabetes; 2007 Apr; 56(4):975-83. PubMed ID: 17395743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy.
    Fawwaz S; Balbaa M; Fakhoury H; Borjac J; Fakhoury R
    Saudi J Kidney Dis Transpl; 2017; 28(2):325-329. PubMed ID: 28352015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreas transplant as treatment to arrest renal function decline in patients with type 1 diabetes and proteinuria.
    Cantarovich D; Perrone V
    Semin Nephrol; 2012 Sep; 32(5):432-6. PubMed ID: 23062983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
    Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R;
    Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23.
    Vardarli I; Baier LJ; Hanson RL; Akkoyun I; Fischer C; Rohmeiss P; Basci A; Bartram CR; Van Der Woude FJ; Janssen B
    Kidney Int; 2002 Dec; 62(6):2176-83. PubMed ID: 12427143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
    Moczulski DK; Fojcik H; Wielgorecki A; Trautsolt W; Gawlik B; Kosiorz-Gorczynska S; Oczko-Wojciechowska M; Wiench M; Strojek K; Zukowska-Szczechowska E; Grzeszczak W
    Diabet Med; 2007 Mar; 24(3):266-71. PubMed ID: 17263765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.
    Grzeszczak W; Moczulski DK; Zychma M; Zukowska-Szczechowska E; Trautsolt W; Szydlowska I
    Kidney Int; 2001 Feb; 59(2):631-6. PubMed ID: 11168944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression profiling in ethnic Malays with type 2 diabetes mellitus, with and without diabetic nephropathy.
    Lokman FE; Seman NA; Ismail AA; Yaacob NA; Mustafa N; Khir AS; Hussein Z; Wan Mohamud WN
    J Nephrol; 2011; 24(6):778-89. PubMed ID: 21360476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC
    Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.
    Imperatore G; Hanson RL; Pettitt DJ; Kobes S; Bennett PH; Knowler WC
    Diabetes; 1998 May; 47(5):821-30. PubMed ID: 9588456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic factors in end-stage renal disease.
    Satko SG; Freedman BI; Moossavi S
    Kidney Int Suppl; 2005 Apr; (94):S46-9. PubMed ID: 15752239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT; Ribeiro AB
    Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications.
    Conserva F; Gesualdo L; Papale M
    J Diabetes Res; 2016; 2016():7934504. PubMed ID: 26798653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.